Neratinib maleate CAS No.915942-22-2 Pharmaceutical Intermediates
Introduction
Neratinib Malt is a special formulation of Neratinib, a potent irreversible tyrosine kinase inhibitor that targets the HER2 receptor. This product is of particular importance in the pharmaceutical industry as it can be used to treat breast cancer, especially in patients who have been previously treated with trastuzumab. The malt formulation improves the solubility and bioavailability of Neratinib, making it more effective in the clinical setting.
As a manufacturer and trader, we take pride in producing high-quality Neratinib Malt to meet the specific needs of our customers in the pharmaceutical industry.
Physical and Chemical Properties
- Appearance: White to off-white powder, stable under standard storage conditions.
- Melting point: about 150-160°C, indicating good thermal stability.
- Solubility: Highly soluble in organic solvents and, due to the malt formula, even higher in aqueous solutions, which increases its bioavailability.
- pH: Neutral to slightly acidic, which can be advantageous in some formulations.
These properties not only enhance the reactivity of the compound but also ensure its compatibility with a wide range of other chemicals used in drug formulations.
1. Targeted cancer therapy: Neratinib specifically inhibits the HER2 receptor, providing a targeted approach for the treatment of HER2-positive breast cancer, which can improve patient outcomes.
2. Improved Bioavailability: The malt formula significantly improves the solubility and absorption rate of Neratinib, thereby achieving more effective dosing and better therapeutic effects.
3. High Purity and Quality: Our stringent quality control process ensures that Neratinib Malt is of high purity, minimizing impurities that may affect the efficacy of the final drug product.
4. Stable and reliable performance: The chemical stability of Neratinib malt ensures that it maintains its properties over time, providing consistent results in a variety of applications.
5. Regulatory Compliance: Our manufacturing processes comply with Good Manufacturing Practices (GMP) and other international regulations, ensuring our products meet the highest safety and quality standards.
Neratinib malt is mainly used in the pharmaceutical industry for the following purposes:
- Breast Cancer Treatment: Neratinib malt is widely used to treat HER2-positive breast cancer, especially in patients who have previously received trastuzumab treatment. It is effective in reducing the risk of cancer recurrence.
- Research and Development: Ongoing research continues to explore the potential of Neratinib in new therapeutic areas, underscoring its importance in the pharmaceutical field.
- Combination Therapy: Neratinib malt may be used in combination with other cancer therapies to enhance the effectiveness of treatment and improve patient outcomes.
As a leading Neratinib Malt manufacturer and trader, we are committed to providing high-quality products that meet the evolving needs of the pharmaceutical industry. Our commitment to excellence, coupled with our integrated approach to production and trading, makes us a trusted partner for pharmaceutical companies around the world. By choosing our Neratinib Malt, you can ensure that your formulations meet the highest standards of quality and efficacy, ultimately helping to improve patient outcomes.
To learn more about our products and services, please contact us today. We look forward to working with you to advance healthcare solutions.